Credit where it is due. Balance put menopause tracking in front of a very large number of women who had been given nothing, and it carries a real library of information behind it. This is not a takedown.
It is about two structural decisions, because structural decisions are the ones a product cannot quietly grow out of. Product details change; where the data lives and who pays the bills do not.
Catch one — the data does not leave
You can keep two years of symptoms in a tracker and find there is no way to take the whole thing out as a file you own. The record lives on the company's servers, under the company's terms, and what you can do with it is whatever the settings screen currently offers.
For a shopping list that is fine. For a medical-adjacent record covering a decade of your own health, it is a dealbreaker — because the entire value of that record is being able to hand it to somebody.
Catch two — the tracker is also a funnel
Several of the best-known menopause trackers sit inside a business that also sells consultations, prescriptions, or supplements; the free tracker is the top of that funnel, and the category's better-known names run the play harder than Balance does.
This does not require anyone to behave badly. It only requires the ordinary thing: a company optimises what it measures, and if what it measures is conversion into services, the tracker drifts toward producing conversions. Your symptoms become the qualifying step.
What to demand of any alternative
- A full export — every row, as a CSV, on demand, without a support ticket and without sitting behind the paid tier.
- On-device by architecture, not by policy. A privacy policy is a promise about what a company will choose to do; on-device storage is a statement about what it is able to do. A record that never reaches a server cannot be breached, sold, or compelled out of it — which matters more in this category since laws like Washington's My Health My Data Act began naming reproductive and menopausal data specifically.
- No services funnel — nobody downstream of your symptom log with something to sell you.
- Built for perimenopause rather than around a 28-day loop. General cycle apps treat this transition as an edge case, and a sixty-day gap should be a reading rather than an error.
- A price stated plainly, so you can see what pays for it.
Where Second Spring stands on each
- Export: a clean CSV with stable columns, every row, on demand — and it keeps working if you stop subscribing. It was the first thing written, not a roadmap item.
- Privacy: the record lives on your phone. No account is required, there is no cloud copy, and the symptom check on the website runs entirely in your browser.
- Funnel: there is none. We do not operate, refer to, or take a share of any clinic, telehealth service, or supplement.
- Built for it: cycle gaps, symptom patterns and the stage markers of the transition are the primary objects, not exceptions handled after the fact.
- Price: $4.99 per month — an honest subscription, stated plainly, with seven days free first.
And the trade-off, stated rather than buried
On-device storage means there is no web dashboard mirroring your phone, and no way for us to restore your record if the phone is lost. Export is how the data travels, and that is a deliberate choice rather than a missing feature — you cannot have both "we can restore it for you" and "we could never be made to produce it".
The switch test
Two questions decide it. Could you get everything out this afternoon, as a file, without asking permission? And does anyone other than you profit from what is in it?
If the answers are no and yes, what you have is not your record of your own health. It is their dataset, wearing your name.
Claims here about other products reflect their public materials as of mid-2026; features change, so check the current ones before you switch. This is educational and it is not medical advice. Second Spring records; the clinician decides.